🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInsurance & AccessVA healthcare GLP-1 access — September 2026

VA healthcare GLP-1 access — September 2026

mike_mod Wed, Feb 18, 2026 at 3:51 PM 23 replies 1,068 viewsPage 1 of 5
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Feb 18, 2026 at 3:51 PM#1

Putting this up for argument rather than for agreement. I have read it twice and I am still not certain what it supports.

Denials are usually procedural rather than clinical, and the order that works reflects that. Get the denial reason in writing, because it names the criterion you failed. Then supply the documentation that criterion asks for — usually documented BMI with a comorbidity, or a failed prior therapy. Then appeal, and ask for a peer-to-peer review, because a prescriber talking to a reviewing clinician resolves a large fraction of denials that written appeals do not. Manufacturer copay assistance is separate and applies mainly to commercial insurance, and patient assistance programmes are means-tested rather than a discount.

Where I think it is weakest: the comparator does most of the work in how this gets reported, and it is not the comparator most people think they are citing.

What I am trying to establish is what actually works on a prior-authorisation denial, as opposed to the list of things that sound like they should work. If the honest answer is that nobody knows, that is a useful answer and I would rather have it.

Note on sourcing:
Figures above are from the primary publication rather than the press summary. If a number here disagrees with one you have, post yours and we will work out which of us is reading a secondary source.
11 6PharmHunterJen, TomTeleRx, DoseLogDan and 8 others
Reply Quote Save Share Report
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Feb 18, 2026 at 4:45 PM#2
mike_mod said:
Denials are usually procedural rather than clinical, and the order that works reflects that.

Telehealth prescriber review for cost and coverage: I've used 2 different telehealth platforms to get my GLP-1 prescription. Comparison:

FeaturePlatform APlatform BPlatform C
Initial Consult$51$91$0
Monthly Follow-up$41Included$51
Prescription SpeedSame day24-48 hoursSame day
Lab MonitoringRequiredOptionalRequired

I settled on the one that required labs — it shows they care about safety, not just prescribing volume.

Last edited: Feb 18, 2026 at 6:45 PM
10 5Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 7 others
Reply Quote Save Share Report
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
Feb 18, 2026 at 5:39 PM#3
mike_mod said:
Denials are usually procedural rather than clinical, and the order that works reflects that.

This is where I part company with the consensus forming above. The affordability discussion here usually stops at individual tactics. At list price this class is out of reach for most of the people who would benefit, and no amount of appeal strategy changes that — it is a pricing problem wearing a paperwork costume.

9 4Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 6 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.BariatricHTX
Senior Member
1,456
7,234
Feb 2024
Houston, TX
Feb 18, 2026 at 6:33 PM#4
Dr.SleepRoch said:
The affordability discussion here usually stops at individual tactics.

Insurance update relevant to cost and coverage: I just got my prior auth approved through Anthem after 4 attempts.

What finally worked: a letter from my endocrinologist documenting BMI history (>3 years), failed diet attempts, comorbidities (NAFLD + metabolic syndrome), and referencing the SELECT trial data.

If your PA keeps getting denied, don't give up. Request a peer-to-peer review between your doctor and the insurance medical director. That's what finally broke through for me.

8 3stefan_berlin, Dr.EM_Chicago, pete_RVA and 5 others
Reply Quote Save Share Report
Dr.DermMIA
Member
456
2,123
May 2024
Miami, FL
Feb 18, 2026 at 11:43 PM#5
KevinCompounds said:
Telehealth prescriber review for cost and coverage: I've used 2 different telehealth platforms to get my GLP-1 prescription.

Second this. The detail I would add is minor and it is already implied above.

Last edited: Feb 19, 2026 at 1:43 AM
7 2SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 4 others
Reply Quote Save Share Report
1235

Similar Threads

Prior authorization success: step-by-step guide with templates5 replies
Cigna now covering Zepbound — how I got approved13 replies
Appeal letter template — denied PA for GLP-1 medications4 replies
Mounjaro savings card — manufacturer program changes 202610 replies
Medicare Part D GLP-1 coverage — what's covered in 202610 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register